Sara Federico, MD, named director of the Solid Tumor Division at St. Jude Children’s Research Hospital
(Memphis, Tenn. – February 7, 2024) St. Jude Children’s Research Hospital today announced Sara M. Federico, MD, has been named director of the institution’s Solid Tumor Division within the Department of Oncology. Federico is an internationally recognized leader in pediatric oncology whose contributions have defined the landscape of treatment for high-risk childhood solid tumors, such as neuroblastoma.
“Dr. Federico’s experience will pave the way for new discoveries that will help advance cure rates for patients with high-risk cancers by identifying, testing and optimizing novel therapeutic strategies,” said Julie R. Park, MD, Department of Oncology chair. “Dr. Federico is an outstanding and thoughtful mentor, and we are excited to see her vision for this department take shape.”
Federico is a leader in clinical research, serving as the principal investigator of numerous clinical trials for the treatment of high-risk solid tumors. Her research focuses on some of the most challenging cancers, such as high-risk neuroblastoma and relapsed sarcomas. Federico is currently leading five clinical trials, including two pioneering new approaches to treat neuroblastoma. The first is a large international Phase 3 study for children with newly-diagnosed high-risk neuroblastoma being conducted through the Children’s Oncology Group, a large pediatric cancer cooperative group. The second is a multi-site Phase 2 study evaluating a novel treatment combination for children with relapsed or refractory neuroblastoma, who historically have a survival rate less than 20%.
“I’m thrilled for this opportunity to lead a collaborative, dedicated team of investigators that is passionate about improving cure rates for children with solid tumors,” said Federico. “Together we hope to advance the field through the translation of critical scientific discoveries into innovative therapies and clinical trials which will ultimately lead to improved patient outcomes.”
Federico joined St. Jude in 2007 as a fellow in pediatric hematology/oncology. She rose to St. Jude faculty level in 2011 as an assistant member in the Division of Solid Malignancies in the Department of Oncology and was appointed as a full faculty member in 2023.
Federico earned her bachelor’s degree from Stanford University and medical degree from Virginia Commonwealth University. She is the recipient of numerous awards including the 2020 Cancer Clinical Investigator Team Leadership Award from the National Cancer Institute (NCI). She also serves on national and international committees such as the NCI National Clinical Trials Network Core Correlative Sciences Committee and the International Neuroblastoma Risk Group Task Force Committee.
Federico replaces Alberto Pappo, MD, who has been director of the Solid Tumor Division since 2010 and is internationally recognized for his work on rare pediatric solid tumors, including sarcoma and melanoma. He will continue his research and mentorship at St. Jude as a member of the division. He remains co-leader of the Development Biology and Solid Tumor Program within the St. Jude Comprehensive Cancer Center, which supports five major interdisciplinary research programs focused on translating basic science discoveries into curative therapies for children with cancer, while minimizing long-term side effects.
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer, sickle cell disease, and other life-threatening disorders. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 60 years ago. St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. To learn more, visit stjude.org, read St. Jude Progress a digital magazine, and follow St. Jude on social media at @stjuderesearch.
St. Jude Media Relations Contact
Cell: (256) 244-2048
Desk: (901) 595-0564
Rae Lyn Hartley
Desk: (901) 595-4419
Cell: (901) 686-2597
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
INDIANAPOLIS – Pioneering cancer researcher Craig B. Thompson, MD, has been named the 2024 winner of the August M. Watanabe Prize in Translational Research.
Awarded by the Indiana University School of Medicine, the Watanabe Prize is one of the nation's largest and most prestigious awards recognizing individuals focused on shepherding scientific discoveries into new therapies for patients. The prize is awarded to a senior investigator who has made a significant contribution to the field of translational science.
Thompson is the former president and chief executive officer ...
Generative artificial intelligence platforms, from ChatGPT to Midjourney, grabbed headlines in 2023. But GenAI can do more than create collaged images and help write emails — it can also design new drugs to treat disease.
Today, scientists use advanced technology to design new synthetic drug compounds with the right properties and characteristics, also known as “de novo drug design.” However, current methods can be labor-, time-, and cost-intensive.
Inspired by ChatGPT’s popularity and wondering if this approach could speed up the drug design process, scientists in the Schmid ...
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, FEBRUARY 7, 2024
MINNEAPOLIS – The drugs used to treat erectile dysfunction may also be associated with a reduced risk of Alzheimer’s disease, according to a study published in the February 7, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that erectile dysfunction drugs reduce the risk of Alzheimer’s disease. It only shows an association.
Erectile dysfunction drugs, which work by dilating blood vessels to allow more blood ...
Imagine a coffee cup sitting on a table. Now, imagine a book partially obscuring the cup. As humans, we still know what the coffee cup is even though we can't see all of it. But a robot might be confused.
Robots in warehouses and even around our houses struggle to identify and pick up objects if they are too close together, or if a space is cluttered. This is because robots lack what psychologists call "object unity," or our ability to identify things even when we can't see all of them.
Researchers at the University of Washington ...
“[...] the results of the studies presented in this review will hopefully provide the impetus for conducting additional preclinical and clinical studies to evaluate RUX in the setting of MM as well as other types of cancer.”
BUFFALO, NY- February 7, 2024 – A new research perspective was published in Oncotarget's Volume 15 on February 5, 2024, entitled, “Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma.”
In this new paper, researchers Ashley Del Dosso, Elizabeth Tadevosyan, and James ...
Although giving blood thinners along with clot-busting medication may help in treating heart attacks, it did not improve 90-day outcomes in people with clot-caused strokes.
Enrollment in a large clinical trial, which had been planned to include more than 1,200 patients with ischemic stroke (clot-caused stroke), was halted after an independent data and safety monitoring board found no indication of benefit among the first 500 patients.
The data analysis for the 500 enrolled participants found giving blood thinners along with clot-busting medication did not increase the risk of bleeding into the brain.
(Santa Barbara, Calif.) — As climate change affects the oceans, coastal communities, particularly those at the front lines of ocean warming and sea level rise, are facing pressures that could threaten their access to aquatic foods.
“Climate change and other economic shocks are impacting how people access seafood, and typically households that are most reliant on seafood, such as those in Pacific Island countries, are most at risk,” said Jacob Eurich, a research associate at UC Santa Barbara’s Marine Science Institute, and a fisheries scientist at the Environmental Defense Fund. Which is why, he added, it is necessary to increase food system resilience in the area, ...
In the US, people of color who are killed by violence or die by suicide lose more potential years of life than white victims, according to a new study, which also explored factors that may contribute to these disparities. Gregory Zimmerman of Northeastern University in Boston, US, and colleagues present these findings in the open-access journal PLOS ONE on February 7, 2024.
Mounting evidence suggests that, among victims of violence in the US, the average number of potential years of life lost—how much longer the victim would have lived if they survived—is greater for people of color than for white people.
To deepen understanding, Zimmerman ...
Almost 1 in 5 Indian adults aged 60+ show signs of mild neurocognitive disorder, according to nationally representative data - more than previously recognized
Article URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0297220
Article Title: Prevalence of DSM-5 mild and major neurocognitive disorder in India: Results from the LASI-DAD
Author Countries: USA, UK, India
Funding: This work was supported by the National Institute on Aging (R01 AG051125 (JL), R01 AG030153 (JL), U01 AG064948 (JL), R01 AG070953 (ALG)). The funders had no role in study design, ...
More biodiverse nature landscapes may better buffer against stress - but only if you notice the difference, per experiment using videos of urban woodland
Article URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0297179
Article Title: Does increasing biodiversity in an urban woodland setting promote positive emotional responses in humans? A stress recovery experiment using 360-degree videos of an urban woodland
Author Countries: UK
Funding: SF received a PhD Studentship funding from the UKRI Economic and Social Research Council, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Sara Federico, MD, named director of the Solid Tumor Division at St. Jude Children’s Research Hospital